ClinConnect ClinConnect Logo
Search / Trial NCT06709391

Fusion or Not- a Randomized Controlled Study on Low Back Pain

Launched by UPPSALA UNIVERSITY · Nov 25, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Low Back Pain, Degenerative Disc Disease, Lumbar Spine, Surgery

ClinConnect Summary

This clinical trial, called "Fusion or Not," is studying the effects of fusion surgery for people suffering from long-term low back pain. Low back pain is a common issue, affecting 8 out of 10 people at some point in their lives, and for some, it can lead to ongoing problems that significantly impact daily life. The trial aims to find out if fusion surgery, which involves joining two or more bones in the spine, is more effective than not performing the surgery when other treatments have failed.

To participate in this study, individuals must be between 25 to 65 years old and have experienced low back pain for at least a year despite trying other treatments. They should have certain types of spinal issues confirmed by MRI scans. Participants will undergo surgery where the decision to perform fusion or not will be made during the procedure, without them knowing which treatment they received for six months. The main goal is to assess the improvement in back function through questionnaires. This study is important because it will help determine whether fusion surgery is a beneficial treatment for low back pain or if other options should be explored.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Low back pain for at least 12 months, in which non-surgical treatments have been unsuccessful
  • History and clinical signs indicating low back pain without signs and symptoms of radiculopathy or vertebral claudication (spinal stenosis)
  • Numeric rating scale back pain of at least 5 (on a 0-10 (worst) scale)
  • Oswestry Disability index of at least 35 (on a 0-100 (worst) scale)
  • One or two level symptomatic degenerative disc disease at level L4/L5 or L5/S1.
  • MRI-findings indicating disc degeneration of one or two lumbar segments (L4/L5 or L5/S1)
  • 25-65 years of age
  • American Society of Anesthesiologists (ASA) classification 1 or 2.
  • No previous spine surgery, except for previous discectomy without fusion on the symptomatic level
  • Written informed consent
  • Exclusion Criteria:
  • Inability to give informed consent
  • Unable to understand Swedish
  • Unable to attend follow-up visits
  • Severe osteoporosis making the patient unfit for surgery
  • Severe cardiovascular, pulmonary or other chronic disease making the patient unfit for surgery
  • Isthmic or degenerative spondylolisthesis, grade 2 or larger
  • New or old fractures
  • Spondylodiscitis
  • Anchylosing spondylitis or other inflammatory process in the spine
  • Active neoplasm
  • Symptoms and clinical signs of nerve root compression or lumbar spinal stenosis (requiring decompressive surgery)
  • Prior lumbar spine surgery (previous discectomy without fusion is not an exclusion criteria)

About Uppsala University

Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.

Locations

Göteborg, , Sweden

Uppsala, , Sweden

Göteborg, Västra Götaland, Sweden

Uppsala, , Sweden

Patients applied

0 patients applied

Trial Officials

Paul Gerdhem, MD, PhD

Principal Investigator

Uppsala University

Christian Carrwik, MD, PhD

Study Director

Uppsala University Hospital

Karin Jensen, MD, MSc Psych

Study Director

Karolinska Institutet

Jens Ivar Brox, MD, PhD

Study Director

Oslo University

Catharina Parai, MD, PhD

Study Director

Vastra Gotaland Region

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported